PlainRecalls
FDA Drug Critical Class I Terminated

Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69.

Reported: June 18, 2014 Initiated: March 26, 2014 #D-1362-2014

Product Description

Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69.

Reason for Recall

Superpotent Drug: Product contains twice the stated amount of midazolam.

Details

Recalling Firm
Pharmakon Pharmaceuticals
Units Affected
80 syringes
Distribution
IN
Location
Noblesville, IN

Frequently Asked Questions

What product was recalled?
Midazolam 0.2 mg/2 mL 0.9% Sodium Chloride syringes, Total dosage: 0.4 mg per 2 mL, Rx Only, Pharmakon Pharmaceuticals, Inc., 14450 Getz Rd, Noblesville, Indiana, NDC 45183-0014-69.. Recalled by Pharmakon Pharmaceuticals. Units affected: 80 syringes.
Why was this product recalled?
Superpotent Drug: Product contains twice the stated amount of midazolam.
Which agency issued this recall?
This recall was issued by the FDA Drug on June 18, 2014. Severity: Critical. Recall number: D-1362-2014.